TransDigm Group Balance Sheet Health
Financial Health criteria checks 0/6
TransDigm Group has a total shareholder equity of $-3.0B and total debt of $22.2B, which brings its debt-to-equity ratio to -733%. Its total assets and total liabilities are $21.6B and $24.6B respectively. TransDigm Group's EBIT is $3.3B making its interest coverage ratio 2.7. It has cash and short-term investments of $4.4B.
Key information
-733.0%
Debt to equity ratio
US$22.15b
Debt
Interest coverage ratio | 2.7x |
Cash | US$4.36b |
Equity | -US$3.02b |
Total liabilities | US$24.60b |
Total assets | US$21.58b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: T7D has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: T7D has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: T7D has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: T7D's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Debt Coverage: T7D's debt is not well covered by operating cash flow (7.8%).
Interest Coverage: T7D's interest payments on its debt are not well covered by EBIT (2.7x coverage).